Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (33,028)

Search Parameters:
Keywords = epidemiology

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
14 pages, 1224 KiB  
Article
Associations Between Urinary Phthalate Metabolites and Decreased Serum α-Klotho Level: A Cross-Sectional Study Among US Adults in Middle and Old Age
by Yuyan Liu, Xiaoyu Zhao, Shuxian Ma and Yongfang Li
Toxics 2024, 12(11), 817; https://doi.org/10.3390/toxics12110817 - 14 Nov 2024
Abstract
Phthalates are widely used chemicals with ubiquitous human exposure. Evidence indicated that phthalate exposure was associated with an increased risk of aging-related diseases. Klotho is a transmembrane protein with anti-aging functions, and its association with phthalates remains unknown. To find the association between [...] Read more.
Phthalates are widely used chemicals with ubiquitous human exposure. Evidence indicated that phthalate exposure was associated with an increased risk of aging-related diseases. Klotho is a transmembrane protein with anti-aging functions, and its association with phthalates remains unknown. To find the association between phthalate exposure and serum α-Klotho, a cross-sectional study was performed in 4482 adults (40–79 years old) who completed the National Health and Nutrition Examination Survey (NHANES) (2007–2016). As shown in the results of multivariable linear regression analyses, mono(carboxynonyl) phthalate (MCNP) and mono-n-butyl phthalate (MBP) were inversely associated with α-Klotho, and the regression coefficients of MCNP and MBP were −1.14 (95% confidence interval (CI): −2.00, −0.27) and −0.08 (95% CI: −0.14, −0.02). Subgroup analyses based on the quartiles of each phthalate metabolite showed that both MCNP and MBP were only inversely associated with α-Klotho in the subgroups of the highest levels. For mono-isobutyl phthalate (MIBP), the inverse association with α-Klotho was only statistically significant in the subgroup of the lowest level, and the regression coefficient was −26.87 (95% CI: −52.53, −1.21). Our findings suggest that α-Klotho might be involved in the association of phthalate exposure with aging-related diseases. Future research investigating the causality between phthalates and α-Klotho and its underlying mechanisms is encouraged. Full article
(This article belongs to the Section Human Toxicology and Epidemiology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Flowchart of this cross-sectional study.</p>
Full article ">Figure 2
<p>Stratified analyses of the interactive effects of confounders on associations of MCNP, MBP and MIBP with α-Klotho. The stratified analyses were performed in subgroups of the highest levels (Q4) of MCNP and MBP, as well as the lowest levels (Q1) of MIBP. Regression models are adjusted for urinary creatinine, sex, age, race, education levels, BMI, hypertension, T2DM, smoking and alcohol drinking. Values in bold are statistically significant. Abbreviations: MCNP: mono(carboxynonyl) phthalate; MBP: mono-n-butyl phthalate; MIBP: mono-isobutyl phthalate; 95% CI: 95% confidence interval.</p>
Full article ">
18 pages, 5380 KiB  
Article
MRI-Based Phenotyping for Osteosarcopenic Adiposity in Subjects from a Population-Based Cohort
by Elke Maurer, Susanne Rospleszcz, Wolfgang Rathmann, Barbara Thorand, Annette Peters, Christopher L. Schlett, Fabian Bamberg and Lena Sophie Kiefer
Geriatrics 2024, 9(6), 150; https://doi.org/10.3390/geriatrics9060150 - 14 Nov 2024
Abstract
Objective: Imaging biomarkers of bone, muscle, and fat by magnetic resonance imaging (MRI) may depict osteopenia, sarcopenia, and adiposity as the three different conditions of osteosarcopenic adiposity (OSA). Methods: Subjects from a prospective, population-based case–control study underwent a health assessment and 3 Tesla [...] Read more.
Objective: Imaging biomarkers of bone, muscle, and fat by magnetic resonance imaging (MRI) may depict osteopenia, sarcopenia, and adiposity as the three different conditions of osteosarcopenic adiposity (OSA). Methods: Subjects from a prospective, population-based case–control study underwent a health assessment and 3 Tesla whole-body MRI scan. Imaging biomarkers of bone (bone marrow fat-fraction (BMFF)), skeletal muscle (skeletal muscle FF (SMFF)), and fat (total adipose tissue (TAT)) were determined. Participants were allocated to one phenotype according to the OSA complex. Results: Among 363 participants forming the study cohort, 81 (22.3%, 48.1% males, 62.4 ± 6.9 years) were allocated into the OSA subgroup. Participants with an OSA phenotype were significantly older compared to all remaining subjects and showed the highest grades of SMFF (all p < 0.005). Together with subjects from the osteopenic sarcopenia group, OSA subjects exhibited the highest amounts of BMFF and together with the three other adiposity-containing subgroups also exhibited the highest BMIs. The highest prevalence of an impaired glucose tolerance as well as significantly higher blood pressure, blood dyslipidemia, and hepatic steatosis was found in the OSA subgroup (all p < 0.005). Conclusions: MR biomarkers of bone, skeletal muscle and fat are feasible for body composition phenotyping and may allow for targeted risk stratification in suspected OSA syndrome. Full article
Show Figures

Figure 1

Figure 1
<p>Measurements of MR imaging biomarkers of bone, muscle and fat. 1.1 Assessment of BMFF in L2 vertebra in coronally acquired 2-point DIXON Vibe sequence. ROIs were manually drawn in fat-selective images (<b>A</b>) and copied to water-selective images (<b>B</b>). 1.2 Assessment of SMFF (<b>A</b>) and CSA (<b>B</b>) of psoas muscle and autochthonous back muscles on transverse multi-echo DIXON sequence. 1.3 Assessment of VAT (<b>A</b>) and SAT (<b>B</b>) on axial dual-echo DIXON sequence.</p>
Full article ">Figure 2
<p>Osteopenia, sarcopenia, and adiposity according to MR imaging biomarkers of bone, muscle, and fat in 363 subjects from general population. Definitions: osteopenia with BMFF &gt; sex-specific median (in total <span class="html-italic">n</span> = 183), adiposity with TAT &gt; sex-specific median (in total <span class="html-italic">n</span> = 179), and sarcopenia with SMFF &gt; sex-specific median (in total <span class="html-italic">n</span> = 179).</p>
Full article ">Figure 3
<p>Example of two subjects from KORA study with higher (<b>A</b>) and lower (<b>B</b>) TAT, SMFF, and BMFF.</p>
Full article ">Figure 4
<p>TAT, SMFF, and BMFF by MRI in study cohort.</p>
Full article ">Figure 4 Cont.
<p>TAT, SMFF, and BMFF by MRI in study cohort.</p>
Full article ">Figure 5
<p>Prevalence of type 2 diabetes mellitus, prediabetes, and normoglycemia based on OGTT in study cohort.</p>
Full article ">
15 pages, 455 KiB  
Article
A Miseducation: Perspectives on Sexuality Education from Black Women in the US South
by Rebecca Hailu Astatke, Yves-Yvette Evans, Stephanie Baker, Monica Simpson and Terri-Ann Thompson
Int. J. Environ. Res. Public Health 2024, 21(11), 1516; https://doi.org/10.3390/ijerph21111516 - 14 Nov 2024
Abstract
Over the last three decades, the receipt of formal sexuality education has declined, with half of adolescents nationwide receiving the minimum Healthy People standard of sexuality education from 2015 to 2019. Further, racial and geographic inequities in sexuality education remain, with Black women [...] Read more.
Over the last three decades, the receipt of formal sexuality education has declined, with half of adolescents nationwide receiving the minimum Healthy People standard of sexuality education from 2015 to 2019. Further, racial and geographic inequities in sexuality education remain, with Black women and girls more likely to receive abstinence-only-until-marriage instruction. We sought to describe Black women’s sexual education in two southern states, North Carolina and Georgia. We conducted a qualitative community-based participatory research study. We held focus-group discussions with forty-nine Black women in Georgia and North Carolina between May 2019 and January 2020. The research team, the reproductive justice organization, and the Research Board reviewed, discussed, and refined themes developed using deductive thematic analysis. Most participants were employed. The median age was twenty-seven. From the participants’ accounts, we observed the inadequacy of sexuality education and the resulting process of unlearning inaccurate, negative information and learning positive and accurate information about sexuality. Participants expressed a desire for accessible, high-quality sexual education for themselves and the next generation that addresses autonomy, pleasure, and consent. Our findings highlight the need for investment in existing community efforts and in creating high-quality, culturally responsive comprehensive sexuality education nationwide to effectively address structural barriers to accessing sexuality and relationship information and skills. Full article
17 pages, 2137 KiB  
Article
Validation of a Set of Clinical Criteria for the Diagnosis of Secondary Progressive Multiple Sclerosis
by Alin Ciubotaru, Daniel Alexa, Cristina Grosu, Lilia Böckels, Ioana Păvăleanu, Alexandra Maștaleru, Maria Magdalena Leon, Roxana Covali, Emanuel Matei Roman, Cătălina Elena Bistriceanu, Cristina Mihaela Ghiciuc, Doina Azoicăi and Emilian Bogdan Ignat
Brain Sci. 2024, 14(11), 1141; https://doi.org/10.3390/brainsci14111141 - 14 Nov 2024
Abstract
Background/Objectives: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by progressive impairment of neuronal transmission due to focal demyelination. The most common form is RRMS (relapsing-remitting multiple sclerosis), which, under the influence of certain factors, can [...] Read more.
Background/Objectives: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by progressive impairment of neuronal transmission due to focal demyelination. The most common form is RRMS (relapsing-remitting multiple sclerosis), which, under the influence of certain factors, can progress to SPMS (secondary progressive multiple sclerosis). Our study aimed to validate the criteria proposed by a working group of the Romanian Society of Neurology versus the criteria proposed by a group of experts from Spain, Karolinska, and Croatia concerning the progression from RRMS to SPMS. Methods: This was done by gathering epidemiological data (age, gender) and by applying clinical tests such as the 9HPT (9-hole peg test), 25FWT (25-foot walk test), and EDSS (expanded disability status scale) tests and the SDMT test (symbol digit modalities test). The present research is a cohort study that included a number of 120 patients diagnosed with MS according to the McDonald Diagnostic Criteria 2017. The study was carried out between January 2023 and April 2024, including patients hospitalized in the Neurology Clinic of the Clinical Rehabilitation Hospital from Iasi, Romania. The data were collected at baseline (T0) and at a 12-month interval (T1). Results: The statistical analysis was conducted using Kaiser–Meyer–Olkin analysis, which indicated a value of 0.683, thus validating the clinical tests used. The correlation matrix and the linear regression for all the tests showed highly significant statistical results. Furthermore, the ROC curve analysis of the criteria suggested by the working group of the Romanian Society of Neurology demonstrated that the EDSS, 9HPT, and 25FWT are highly sensitive in diagnosing SPMS, an opinion that is shared with the Spanish experts, but not with the Karolinska expert panel. Using the criteria given by the Croatian expert group in the ROC curve analysis showed that only the EDSS was strongly significant for the progression to the SPMS phase. Conclusions: In conclusion, all clinical methods used demonstrated that they are valid and can contribute to identifying patients with an increased risk of progression. The model proposed by the Romanian Society of Neurology working group is similar to other countries’ expert opinions and can be used to detect the risk of disease progression and establish a more tailored therapeutic management of SPMS. Full article
(This article belongs to the Section Neuropharmacology and Neuropathology)
Show Figures

Figure 1

Figure 1
<p>Regression line regarding the correlation between the EDSS score at T0 and T1.</p>
Full article ">Figure 2
<p>Regression line regarding the correlation at T0 and T1 for 9HPT, 25 FWT, and SDMT.</p>
Full article ">Figure 2 Cont.
<p>Regression line regarding the correlation at T0 and T1 for 9HPT, 25 FWT, and SDMT.</p>
Full article ">Figure 3
<p>ROC curve in relation to the types of ”events” that define the form of SPMS according to the criteria of the working group of the Romanian Society of Neurology.</p>
Full article ">Figure 4
<p>The ROC curve in relation to the types of “events” that define the type of the SPMS according to the criteria of the Spanish “expert” group.</p>
Full article ">Figure 5
<p>The ROC curve in relation to the types of ”event” that define the type of SPMS according to the Karolinka expert group criteria.</p>
Full article ">Figure 6
<p>The ROC curve in relation to the types of “events” that define the shape of the SPMS according to the criteria of the Croatian expert group.</p>
Full article ">
15 pages, 772 KiB  
Article
Use of Mobile Phones and Radiofrequency-Emitting Devices in the COSMOS-France Cohort
by Isabelle Deltour, Florence Guida, Céline Ribet, Marie Zins, Marcel Goldberg and Joachim Schüz
Int. J. Environ. Res. Public Health 2024, 21(11), 1514; https://doi.org/10.3390/ijerph21111514 - 14 Nov 2024
Abstract
COSMOS-France is the French part of the COSMOS project, an international prospective cohort study that investigates whether the use of mobile phones and other wireless technologies is associated with health effects and symptoms (cancers, cardiovascular diseases, neurologic pathologies, tinnitus, headaches, or sleep and [...] Read more.
COSMOS-France is the French part of the COSMOS project, an international prospective cohort study that investigates whether the use of mobile phones and other wireless technologies is associated with health effects and symptoms (cancers, cardiovascular diseases, neurologic pathologies, tinnitus, headaches, or sleep and mood disturbances). Here, we provide the first descriptive results of COSMOS-France, a cohort nested in the general population-based cohort of adults named Constances. Methods: A total of 39,284 Constances volunteers were invited to participate in the COSMOS-France study during the pilot (2017) and main recruitment phase (2019). Participants were asked to complete detailed questionnaires on their mobile phone use, health conditions, and personal characteristics. We examined the association between mobile phone use, including usage for calls and Voice over Internet Protocol (VoIP), cordless phone use, and Wi-Fi usage with age, sex, education, smoking status, body mass index (BMI), and handedness. Results: The participation rate was 48.4%, resulting in 18,502 questionnaires in the analyzed dataset. Mobile phone use was reported by 96.1% (N = 17,782). Users reported typically calling 5–29 min per week (37.1%, N = 6600), making one to four calls per day (52.9%, N = 9408), using one phone (83.9%, N = 14,921) and not sharing it (80.4% N = 14,295), mostly using the phone on the side of the head of their dominant hand (59.1%, N = 10,300), not using loudspeakers or hands-free kits, and not using VoIP (84.9% N = 15,088). Individuals’ age and sex modified this picture, sometimes markedly. Education and smoking status were associated with ever use and call duration, but neither BMI nor handedness was. Cordless phone use was reported by 66.0% of the population, and Wi-Fi use was reported by 88.4%. Conclusion: In this cross-sectional presentation of contemporary mobile phone usage in France, age and sex were important determinants of use patterns. Full article
(This article belongs to the Special Issue Epidemiology of Lifestyle-Related Diseases)
Show Figures

Figure 1

Figure 1
<p>Flow chart for participation in the COSMOS-France study. Note: * excluded from the calculation of the participation rate.</p>
Full article ">Figure 2
<p>Description of laterality of mobile phone use among left-handed, ambidextrous, and right-handed participants of Cosmos-France, 2017–19. Percentages are shown excluding missing values, presented in white font.</p>
Full article ">
15 pages, 2613 KiB  
Article
Healthcare Utilization Among Youth with Chronic Illness Receiving Care at a Large Urban Academic Healthcare System
by William Daniel Soulsby, Linda S. Franck, Emily Perito, Paul Brakeman, Addison Cuneo, Laura Quill, John Boscardin and Emily von Scheven
Healthcare 2024, 12(22), 2278; https://doi.org/10.3390/healthcare12222278 - 14 Nov 2024
Abstract
Background/Objective: We sought to understand healthcare utilization and barriers to care among youth with chronic illness who interact frequently with the healthcare system. Methods: This was a retrospective analysis of healthcare utilization for youth ≤25 years of age with chronic illness during one [...] Read more.
Background/Objective: We sought to understand healthcare utilization and barriers to care among youth with chronic illness who interact frequently with the healthcare system. Methods: This was a retrospective analysis of healthcare utilization for youth ≤25 years of age with chronic illness during one calendar year (1 January 2021–31 December 2021) in a single urban academic healthcare system. Inclusion criteria were (1) having at least one healthcare encounter in the calendar year of 2021 and (2) having at least six healthcare encounters over the preceding 3-year period or having a qualifying chronic illness. Demographic and clinical characteristics were collected along with self-reported and derived social determinants of health. Univariable and multivariable regression models were created to identify predictors of missed clinic visits, telehealth use, and activated patient portal accounts. Results: The cohort (N = 14,245) was demographically, clinically, and socioeconomically diverse. The youth had frequent clinic visits (median 9, IQR 4–18), multiple subspecialty care referrals (median 4, 1–8), were prescribed multiple medications (median 6, 3–10), and a high proportion received emergency department (18%) or inpatient treatment (15%). Race and public insurance were significant predictors of missed clinic visits and telehealth use. Primary language was a significant predictor of patient portal activation. Conclusions: Youth with chronic illness who are high users of the healthcare system face a high burden of clinic, emergency room, and hospital visits, referrals, and medications. Systematic efforts to lower the healthcare burden and improve care access should address existing racial and socioeconomic disparities affecting this patient population, who are likely to need frequent healthcare over their lifetime. Full article
(This article belongs to the Section Chronic Care)
Show Figures

Figure 1

Figure 1
<p>Most common diagnoses among youth (up to age 25) defined as high users of the medical system seen at University of California, San Francisco (UCSF) Health in 2021. Acronyms (T1DM = Type I Diabetes Mellitus; ADHD = Attention Deficit Hyperactivity Disorder; IBD = Inflammatory Bowel Disease; JIA = Juvenile Idiopathic Arthritis).</p>
Full article ">Scheme 1
<p>(<b>A</b>) Geographic distribution of the high healthcare use cohort of youth (up to age 25) with chronic illnesses in 2021. (<b>B</b>). Geographic distribution of the same cohort within California.</p>
Full article ">
17 pages, 1126 KiB  
Article
Identification of Salmonella Serogroups and Distinction Between Typhoidal and Non-Typhoidal Salmonella Based on ATR-FTIR Spectroscopy
by Maira Napoleoni, Stefano Ceschia, Elisa Mitri, Elisa Eleonora Beneitez, Valentina Silenzi, Monica Staffolani, Elena Rocchegiani, Giuliana Blasi and Elisa Gurian
Microorganisms 2024, 12(11), 2318; https://doi.org/10.3390/microorganisms12112318 - 14 Nov 2024
Abstract
Salmonellosis is the second-most commonly reported foodborne gastrointestinal infection in the European Union and a major contributor to foodborne outbreaks globally. Salmonella serotyping differentiates typhoidal strains requiring antibiotic therapy (e.g., serovars Typhi, Paratyphi A, Paratyphi B-d-tartrate negative, Paratyphi C) from typically self-limiting non-typhoidal [...] Read more.
Salmonellosis is the second-most commonly reported foodborne gastrointestinal infection in the European Union and a major contributor to foodborne outbreaks globally. Salmonella serotyping differentiates typhoidal strains requiring antibiotic therapy (e.g., serovars Typhi, Paratyphi A, Paratyphi B-d-tartrate negative, Paratyphi C) from typically self-limiting non-typhoidal Salmonella (NTS) strains, making precise identification essential for appropriate treatment and epidemiological tracking. At the same time, the ability to identify the serogroup of Salmonella, regardless of which of the above two groups it belongs to, provides an important initial epidemiological indication that is useful for case management by competent health authorities. This study evaluates the effectiveness of ATR-FTIR spectroscopy coupled with a machine learning algorithm to identify four key Salmonella enterica serogroups (B, C1, D1—including typhoidal strains such as S. Typhi—and E1) directly from solid monomicrobial cultures without sample pretreatment. The system was paired with I-dOne software v2.2 already able to detect Salmonella spp., possibly leading to the characterisation of both the species and serotype from one colony. The multivariate classification model was trained and validated with 248 strains, with an overall accuracy of >98% over 113 samples. This approach offers a potential rapid alternative for clinical labs without serotyping facilities. Full article
(This article belongs to the Section Microbial Biotechnology)
Show Figures

Figure 1

Figure 1
<p>Typical ATR-FTIR spectrum of a generic microorganism and simplified band assignment.</p>
Full article ">Figure 2
<p>I-dOne’s workflow.</p>
Full article ">Figure 3
<p>The t-SNE plots computed (<b>A</b>) on a representative subset of the database and (<b>B</b>) only for serogroup D1 and serovar <span class="html-italic">S</span>. Typhi, coloured by serogroup membership.</p>
Full article ">Figure 4
<p>The second derivative of the fingerprint region. Data from all of the spectra and media are stacked and aggregated by class (mean and first standard deviation).</p>
Full article ">
10 pages, 1164 KiB  
Article
The Social Determinants of Health in a Cohort of Romanian Patients with Diabetic and Nondiabetic Neuropathy
by Georgeta Inceu, Adriana Rusu, Norina Alinta Gavan and Cornelia Bala
J. Clin. Med. 2024, 13(22), 6858; https://doi.org/10.3390/jcm13226858 - 14 Nov 2024
Abstract
Background/Objectives: The importance of the social determinants of health (SODHs) in diabetic and nondiabetic neuropathy has recently gained more attention. This retrospective study examined the correlation of incident diabetic neuropathy and neuropathy of other etiologies with SODH in Romania. Methods: All [...] Read more.
Background/Objectives: The importance of the social determinants of health (SODHs) in diabetic and nondiabetic neuropathy has recently gained more attention. This retrospective study examined the correlation of incident diabetic neuropathy and neuropathy of other etiologies with SODH in Romania. Methods: All cases with the primary or secondary discharge diagnosis codes of neuropathy reported across Romania in 2019 were analyzed. The crude incidence rate was calculated per 100,000 persons for the whole population resident in Romania on the 1 July 2019. As SODHs sex, gross domestic product (GDP) per capita, unemployment rate, and the number of physicians/1000 persons were evaluated. Results: In total, 207,026 hospitalizations with a discharge diagnosis of neuropathy were recorded. Of these, 80,480 had a discharge diagnosis of diabetic neuropathy, with an incidence rate of 414.97 cases/100,000 persons. The incidence rate of diabetic neuropathy by county was correlated with the corresponding GDP (p = 0.013) and unemployment rate (p = 0.001). By sex, the correlation with GDP remained significant only for women (p = 0.010), while the correlation with unemployment rate remained significant in both sexes. No correlation was observed with the number of physicians/1000 persons/county. The incidence rate of neuropathy of other etiology was 652.49 cases/100,000 persons. No correlation between the incidence rate of neuropathy of other etiology by county and the corresponding GDP, unemployment rate or number of physicians/1000 persons was observed neither in the total sample nor by sex. Conclusions: Lower socioeconomic status was correlated with a higher incidence rate of hospitalized diabetic neuropathy and not with neuropathies of other etiologies. Full article
(This article belongs to the Section Endocrinology & Metabolism)
Show Figures

Figure 1

Figure 1
<p>Incidence of hospitalized cases with a discharge diagnosis of neuropathy—total cases (<b>A</b>), by age category (<b>B</b>), and sex (<b>C</b>).</p>
Full article ">Figure 1 Cont.
<p>Incidence of hospitalized cases with a discharge diagnosis of neuropathy—total cases (<b>A</b>), by age category (<b>B</b>), and sex (<b>C</b>).</p>
Full article ">Figure 2
<p>Variation in incident hospitalized cases with a discharge diagnosis of diabetic neuropathy (<b>A</b>) and neuropathies of other etiologies (<b>B</b>) by county of origin, sorted according to the gross domestic product per capita (<b>A1</b>,<b>B1</b>) and according to the unemployment rate (<b>A2</b>,<b>B2</b>). GDP = gross domestic product; USD = US dollar; ρ = Spearman’s ρ correlation coefficient.</p>
Full article ">
14 pages, 275 KiB  
Article
Assessing Barriers and Difficulties to Healthcare Access Among Syrian Refugees in Jordan: An Observational Study
by Yazid Mohammed Gougazeh, Mahmoud Ola AlHussami, Konstantinos Tsaras, Wafa Hamad Almegewly, Savvato Karavasileiadou and Christos Kleisiaris
Healthcare 2024, 12(22), 2276; https://doi.org/10.3390/healthcare12222276 - 14 Nov 2024
Abstract
(1) Background: Worldwide, refugees may have some difficulties in accessing healthcare services. However, little is known about the factors that may predict the level of accessibility to the public healthcare system in the host countries. (2) Aim: To examine the level of accessibility [...] Read more.
(1) Background: Worldwide, refugees may have some difficulties in accessing healthcare services. However, little is known about the factors that may predict the level of accessibility to the public healthcare system in the host countries. (2) Aim: To examine the level of accessibility of Syrian refugees to the public healthcare system in Jordan and further to identify the prediction of socioeconomic factors and barriers to healthcare access. (3) Methods: A cross-sectional study was conducted with a convenient sample of 356 Syrian refugees residing outside camps (Irbid, Ajloun, and Jarash). Data were collected using the Access to Healthcare Services Scale instrument (adopted from the Canadian Community Health Survey), which is composed of 2 sections: the general access scale (8 items) and the difficulties scale (20 items). One-way ANOVA test and independent t-test were used to examine epidemiological correlations among variables, whereas a hierarchical linear regression model was used to examine the predictability of socioeconomic factors and barriers to overall access to the public healthcare system by exploring the incremental impact of additional predictors. (4) Results: the mean age of the 356 participants was 35.22 years old, 56.5% were female, 67.4% were married, most of them 46.1% have secondary education, and non-employed 69.9%. Significant associations were observed among participants with different marital status (p < 0.001), educational level (mean 11.85 vs. 19.85, p < 0.001), working status (15.47 vs. 17.93, p < 0.001), family household number (16.42 vs. 17.0, p < 0.001), and health insurance (none: 15.50 vs. governmental 24.50, p < 0.001). Multivariate analysis revealed that the most important factors that may predict the overall access to healthcare services were: family monthly income (beta −0.19, p < 0.001), household family number (beta 0.17, <0.001), health insurance (beta −0.09, p = 0.047), and barriers (beta −0.43, <0.001), even after adjusting for potential confounding effects: sex, age, educational level, and place of residence. (5) Conclusions: Our findings indicate that socioeconomic factors and barriers may considerably predict overall access to public healthcare in Jordan. It is crucially important, therefore, for the Jordanian government and international organizations to create and develop strategic plans and programs that enhance refugees’ access to health services, positively impacting their health and wellness. Full article
14 pages, 745 KiB  
Article
Exploring Demand: Challenges and Opportunities for Free-From and Organic Foods in Portuguese Market
by Teresa Lemos, Marta Vasconcelos, Sérgio Sousa, Simão Pinho, Ana M. Gomes and Elisabete Pinto
Appl. Sci. 2024, 14(22), 10492; https://doi.org/10.3390/app142210492 - 14 Nov 2024
Viewed by 2
Abstract
The rising prevalence of food intolerances and increased health and environmental consciousness has driven the demand for free-from (FF) and organic products. This study aims to analyze consumer needs, motivations, and challenges related to these products in Portugal through an online survey with [...] Read more.
The rising prevalence of food intolerances and increased health and environmental consciousness has driven the demand for free-from (FF) and organic products. This study aims to analyze consumer needs, motivations, and challenges related to these products in Portugal through an online survey with 2268 eligible responses, with a median age of the participants of 41 years. The sample was predominantly female (76.9%), with male participants comprising 23.1% of the sample. The results show that 97.4% of the respondents were aware of FF products, with 60.0% being regular consumers, particularly of lactose-free milk and gluten-free bread and biscuits. Significant market gaps were identified in the variety of FF bread (62.8%), pastries (49.0%), and cookies (38.4%). The consumers identified high prices (84.9%) and excessive sugar/fat content (52.1%) as the main drawbacks of FF products currently on the market. The women showed greater knowledge and purchase levels compared to the men. The trust in organic certification was low (21.4%), with skepticism higher among the lower-income and male participants. Despite this, 78.1% believed in the health benefits of organic products, and 72.2% agreed that increased demand could lower prices. Overall, this study highlights the need for greater product variety, improved transparency, and consumer education to enhance market trust and accessibility. Full article
(This article belongs to the Special Issue Data Statistics for Epidemiological Research)
Show Figures

Figure 1

Figure 1
<p>Free-from products desired in the market (<span class="html-italic">n</span>).</p>
Full article ">Figure 2
<p>Negative issues of the free-from products available on the market (<span class="html-italic">n</span>).</p>
Full article ">Figure 3
<p>The main drivers in the choice of a free-from product (<span class="html-italic">n</span>).</p>
Full article ">
18 pages, 3173 KiB  
Article
Interrelation Between Pathoadaptability Factors and Crispr-Element Patterns in the Genomes of Escherichia coli Isolates Collected from Healthy Puerperant Women in Ural Region, Russia
by Yulia Mikhaylova, Marina Tyumentseva, Konstantin Karbyshev, Aleksandr Tyumentsev, Anna Slavokhotova, Svetlana Smirnova, Andrey Akinin, Andrey Shelenkov and Vasiliy Akimkin
Pathogens 2024, 13(11), 997; https://doi.org/10.3390/pathogens13110997 - 14 Nov 2024
Viewed by 29
Abstract
Escherichia coli is a commensal and opportunistic bacterium widely distributed around the world in different niches including intestinal of humans and animals, and its extraordinary genome plasticity led to the emergence of pathogenic strains causing a wide range of diseases. E. coli is [...] Read more.
Escherichia coli is a commensal and opportunistic bacterium widely distributed around the world in different niches including intestinal of humans and animals, and its extraordinary genome plasticity led to the emergence of pathogenic strains causing a wide range of diseases. E. coli is one of the monitored species in maternity hospitals, being the main etiological agent of urogenital infections, endometriosis, puerperal sepsis, and neonatal diseases. This study presents a comprehensive analysis of E. coli isolates obtained from the maternal birth canal of healthy puerperant women 3–4 days after labor. According to whole genome sequencing data, 31 sequence types and six phylogenetic groups characterized the collection containing 53 isolates. The majority of the isolates belonged to the B2 phylogroup. The data also includes phenotypic and genotypic antibiotic resistance profiles, virulence factors, and plasmid replicons. Phenotypic and genotypic antibiotic resistance testing did not demonstrate extensive drug resistance traits except for two multidrug-resistant E. coli isolates. The pathogenic factors revealed in silico were assessed with respect to CRISPR-element patterns. Multiparametric and correlation analyses were conducted to study the interrelation of different pathoadaptability factors, including antimicrobial resistance and virulence genomic determinants carried by the isolates under investigation. The data presented will serve as a valuable addition to further scientific investigations in the field of bacterial pathoadaptability, especially in studying the role of CRISPR/Cas systems in the E. coli genome plasticity and evolution. Full article
(This article belongs to the Special Issue Detection and Epidemiology of Drug-Resistant Bacteria)
Show Figures

Figure 1

Figure 1
<p>Sequence type distribution among different groups (“No CRISPR/No Cas”, “CRISPR/No Cas”, “Type I-E”, and “Type I-F”) of Crie-Pu <span class="html-italic">E. coli</span> isolates.</p>
Full article ">Figure 2
<p>Phylogenetic groups’ distribution within different CRISPR-elements groups (“No CRISPR/No Cas”, “CRISPR/No Cas”, “Type I-E”, and “Type I-F”) for Crie-Pu <span class="html-italic">E. coli</span> isolates. (<b>a</b>) Crie-Pu isolates bearing neither CRISPR array, nor cas cassette; (<b>b</b>) Crie-Pu isolates with confirmed CRISPR arrays, but without <span class="html-italic">cas</span> cassettes; (<b>c</b>) Crie-Pu isolates with Type I-E CRISPR/Cas systems; (<b>d</b>) Crie-Pu isolates with Type I-F CRISPR/Cas systems.</p>
Full article ">Figure 3
<p>Maximum likelihood phylogenetic tree of the full-length Type I-E <span class="html-italic">cas3</span> gene sequences of clinical Crie-Pu <span class="html-italic">E. coli</span> isolates (shown as ‘Pu’ for brevity) and reference <span class="html-italic">Escherichia</span> isolates obtained from CRISPRCasdb. Bootstrap test (1000 replicates) was applied. Bootstrap values are indicated at the branch nodes. Antibiotic-resistant Crie-Pu <span class="html-italic">E. coli</span> isolates are marked with black triangles, antibiotic-sensitive Crie-Pu <span class="html-italic">E. coli</span> isolates are marked with white triangles. The genes identified in this study are indicated by the short isolate names, and the reference sequences are shown by GenBank accession number and strain name.</p>
Full article ">Figure 4
<p>Maximum likelihood phylogenetic tree of the full-length Type I-F <span class="html-italic">cas3</span> gene sequences of clinical Crie-Pu <span class="html-italic">E. coli</span> isolates (shown as ‘Pu’ for brevity) and reference Escherichia isolates obtained from CRISPRCas database. Bootstrap test (1000 replicates) was applied. Bootstrap values are indicated at the branch nodes. Antibiotic-resistant Crie-Pu <span class="html-italic">E. coli</span> isolates are marked with black triangles, antibiotic-sensitive Crie-Pu <span class="html-italic">E. coli</span> isolates are marked with white triangles. The genes identified in this study are indicated by the short isolate names, and the reference sequences are shown by GenBank accession number and strain name.</p>
Full article ">Figure 5
<p>The number of antibiotic resistance genes in the analyzed groups of the Crie-Pu <span class="html-italic">E. coli</span> isolates. Asterisks denote significant difference (** <span class="html-italic">p</span> ≤ 0.01).</p>
Full article ">Figure 6
<p>Virulence genes number in the analyzed groups of the Crie-Pu <span class="html-italic">E. coli</span> isolates. Asterisk denotes significant difference (* <span class="html-italic">p</span> ≤ 0.05).</p>
Full article ">Figure 7
<p>Plasmid replicons number in the analyzed groups of the Crie-Pu <span class="html-italic">E. coli</span> isolates. Asterisk denotes significant difference (* <span class="html-italic">p</span> ≤ 0.05).</p>
Full article ">Figure 8
<p>The CRISPR arrays spacers count in the analyzed groups of the Crie-Pu <span class="html-italic">E. coli</span> isolates. Asterisks denote significant differences (** <span class="html-italic">p</span> ≤ 0.01, **** <span class="html-italic">p</span> ≤ 0.0001).</p>
Full article ">Figure 9
<p>CRISPR array spacers distribution in Type I-E and Type I-F Crie-Pu <span class="html-italic">E. coli</span> isolates according to CRISPRTarget web service. Asterisks denote significant differences (*** <span class="html-italic">p</span> ≤ 0.001, **** <span class="html-italic">p</span> ≤ 0.0001).</p>
Full article ">
11 pages, 991 KiB  
Article
The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US
by Aleksandar Ilic, Maria J. Tort, Alejandro Cane, Raymond A. Farkouh and Mark H. Rozenbaum
Vaccines 2024, 12(11), 1279; https://doi.org/10.3390/vaccines12111279 - 14 Nov 2024
Viewed by 53
Abstract
(1) Background/Objectives: Two pneumococcal conjugate vaccines, 15-(PCV15) and 20-(PCV20) valent formulations, are routinely recommended for US children in a 3+1 schedule. The first three doses are administered during the first year of life at 2, 4, and 6 months, while a booster dose [...] Read more.
(1) Background/Objectives: Two pneumococcal conjugate vaccines, 15-(PCV15) and 20-(PCV20) valent formulations, are routinely recommended for US children in a 3+1 schedule. The first three doses are administered during the first year of life at 2, 4, and 6 months, while a booster dose is given at 12 to 15 months. This study evaluated the health and economic effects of the PCV20 infant series within the first year of life compared to PCV15. (2) Methods: Using a decision-analytic model, we calculated the health and economic effects of introducing PCV15 or PCV20 for five subsequent birth cohorts. Epidemiological data were drawn from peer-reviewed studies and estimates for vaccine effectiveness were extrapolated from established PCV13 effectiveness and PCV7 efficacy studies. Direct medical costs related to the disease treatment were extracted from the literature and inflated to 2024 dollars. (3) Results: Over the course of five years, the implementation of PCV20 vaccination for newborns in the United States, compared to PCV15, is projected to prevent an additional 220 cases of invasive pneumococcal disease, 6542 cases of community-acquired pneumonia, and 112,095 cases of otitis media within the first year of life across five subsequent birth cohorts. This strategy could prevent 66 infant deaths linked to these illnesses and confer extra health gains, amounting to 5058 years of life and 5037 quality-adjusted life years. These prevented cases are estimated to save approximately USD 147 million over 5 years. (4) Conclusions: This study demonstrated that vaccinating with PCV20 during the first 12 months of life compared to PCV15 in the US would yield a substantially greater health and economic return due to the five additional serotypes covered by PCV20. Full article
(This article belongs to the Special Issue The Effectiveness of Pneumococcal Conjugate Vaccines)
Show Figures

Figure 1

Figure 1
<p>Model schematic.</p>
Full article ">Figure 2
<p>Results of the Deterministic Sensitivity Analysis (DSA)–PCV20 vs. PCV15 costs averted.</p>
Full article ">Figure 3
<p>Results of the Deterministic Sensitivity Analysis (DSA)–PCV20 vs. PCV15 QALYs gained.</p>
Full article ">
10 pages, 409 KiB  
Systematic Review
The Use of Blood-Based Biomarkers in the Prediction of Colorectal Neoplasia at the Time of Primary Screening Colonoscopy Among Average-Risk Patients: A Systematic Literature Review
by R. Liam Sutherland, Dylan E. O’Sullivan, Yibing Ruan, Kristian Chow, Brittany Mah, Dayoung Kim, Robert B. Basmadjian, Nauzer Forbes, Winson Y. Cheung, Robert J. Hilsden and Darren R. Brenner
Cancers 2024, 16(22), 3824; https://doi.org/10.3390/cancers16223824 - 14 Nov 2024
Viewed by 73
Abstract
Background/Objectives: Risk prediction models (RPMs) for colorectal cancer (CRC) could facilitate risk-based screening. Models incorporating biomarkers may improve the utility of current RPMs. We performed a systematic review of studies reporting RPMs for CRC that evaluated the impact of blood-based biomarkers on clinical [...] Read more.
Background/Objectives: Risk prediction models (RPMs) for colorectal cancer (CRC) could facilitate risk-based screening. Models incorporating biomarkers may improve the utility of current RPMs. We performed a systematic review of studies reporting RPMs for CRC that evaluated the impact of blood-based biomarkers on clinical outcome prediction at the time of screening colonoscopy in average-risk populations. Methods: We conducted a search of MEDLINE, Web of Science, and PubMed databases from inception through April 2024. Studies that developed or validated a model to predict risk of CRC or its precursors were included. Studies were limited to those including patients undergoing average-risk CRC screening. Results: Sixteen studies published between 2015 and 2024 were included. Outcomes included CRC (16 studies) and high-risk adenomas (1 study). Using a complete blood count was the most common biomarker and was able to achieve an AUC of 0.82 and a specificity of 0.88. Other blood-based biomarkers included were various serum proteins/metabolites/enzymes, plasma metabolites, insulin-related factors, and anemia markers. The highest-performing model, with an AUC of 0.99, involved the use of a plasma metabolite panel. Conclusions: The evidence base of RPMs for CRC screening is expanding and incorporating biomarkers, which remain a prominent aspect of model discovery. Most RPMs included a lack of internal/external validation or discussion as to how the model could be implemented clinically. As biomarkers improve the discriminatory potential of RPMs, more research is needed for the evaluation and implementation of RPMs within existing CRC screening frameworks. Full article
(This article belongs to the Special Issue Colorectal Cancer Awareness Month)
Show Figures

Figure 1

Figure 1
<p>PRISMA flow diagram to represent the flow of studies searched, screened, and included/excluded.</p>
Full article ">
11 pages, 590 KiB  
Article
Osteopontin and Clinical Outcomes in Hemodialysis Patients
by Claudia Torino, Federico Carbone, Patrizia Pizzini, Sabrina Mezzatesta, Graziella D’Arrigo, Mercedes Gori, Luca Liberale, Margherita Moriero, Cristina Michelauz, Federica Frè, Simone Isoppo, Aurora Gavoci, Federica La Rosa, Alessandro Scuricini, Amedeo Tirandi, Davide Ramoni, Francesca Mallamaci, Giovanni Tripepi, Fabrizio Montecucco and Carmine Zoccali
Biomedicines 2024, 12(11), 2605; https://doi.org/10.3390/biomedicines12112605 - 14 Nov 2024
Viewed by 98
Abstract
Background/Objectives: Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) are significant public health issues, with cardiovascular morbidity and mortality being the leading causes of death in hemodialysis patients. Osteopontin (OPN), a multifunctional glycoprotein, has emerged as a potential biomarker for vascular disease [...] Read more.
Background/Objectives: Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) are significant public health issues, with cardiovascular morbidity and mortality being the leading causes of death in hemodialysis patients. Osteopontin (OPN), a multifunctional glycoprotein, has emerged as a potential biomarker for vascular disease in CKD due to its role in inflammation, tissue remodeling, and calcification. Methods: This cohort study included 1124 hemodialysis patients from the PROGREDIRE study, a registry involving 35 dialysis units in Southern Italy. Serum osteopontin levels were measured using enzyme-linked immunosorbent assay (ELISA). The primary endpoints were all-cause and cardiovascular mortality. Multivariate Cox regression analyses were performed to assess the association between osteopontin levels and mortality, adjusting for traditional risk factors, biomarkers of inflammation, nutritional status, and ESKD-related factors. Results: During a mean follow-up of 2.8 years, 478 patients died, 271 from cardiovascular causes. Independent correlates of osteopontin included alkaline phosphatase and parathyroid hormone. Elevated osteopontin levels were significantly associated with increased all-cause mortality (HR 1.19, 95% CI 1.09–1.31, p < 0.001) and cardiovascular mortality (HR 1.22, 95% CI 1.08–1.38, p = 0.001) after adjusting for confounders. Conclusions: Elevated osteopontin levels are associated with increased all-cause and cardiovascular mortality in hemodialysis patients. These findings implicate osteopontin in the high risk for death and cardiovascular disease in the hemodialysis population. Intervention studies are needed to definitively test this hypothesis. Full article
(This article belongs to the Special Issue Emerging Trends in Kidney Disease)
Show Figures

Figure 1

Figure 1
<p>Absence of effect modification on the link between OPN and all-cause (<b>left</b> panel) and CV (<b>right</b> panel) mortality.</p>
Full article ">
10 pages, 628 KiB  
Article
Regional Variation in Urinary Escherichia coli Resistance Among Outpatients in Washington State, 2013–2019
by Hannah T. Fenelon, Stephen E. Hawes, Hema Kapoor, Ann E. Salm, Jeff Radcliff and Peter M. Rabinowitz
Microorganisms 2024, 12(11), 2313; https://doi.org/10.3390/microorganisms12112313 - 14 Nov 2024
Viewed by 123
Abstract
Escherichia coli (E. coli) is a predominant pathogen of urinary tract infections (UTIs) in the United States. We analyzed resistance patterns by geographic location in Washington State to assess the need for regional antibiograms. The study included urinary E. coli antibiotic [...] Read more.
Escherichia coli (E. coli) is a predominant pathogen of urinary tract infections (UTIs) in the United States. We analyzed resistance patterns by geographic location in Washington State to assess the need for regional antibiograms. The study included urinary E. coli antibiotic susceptibility tests performed by Quest Diagnostics on Washington outpatient isolates from 2013 to 2019. We conducted logistic regressions with robust standard errors for five antibiotics (ceftriaxone, ciprofloxacin, gentamicin, trimethoprim-sulfamethoxazole), with isolates classified as “susceptible” or “resistant” for each antibiotic tested. Analyses were adjusted for sex, year of isolate collection, and age group (0–18, 19–50, >50). The state’s nine Public Health Emergency Preparedness Regions (PHEPRs) were used as the geographic level for the analysis. The analysis included 40,217 isolates (93% from females, mean age 47 years). Compared to the Central PHEPR (containing Seattle), most other regions had significantly lower adjusted prevalence ratios (aPORs) of antimicrobial resistance (AMR), with aPORs as low as 0.20 (95% CI: 0.06–0.63) for ceftriaxone in the North Central region. Additionally, no regions had significantly higher aPOR of resistance for any antibiotic. Differences in resistance between the Central and other regions varied by antibiotic with the largest difference for ceftriaxone and smallest for ampicillin. The finding of regional variation of E. coli AMR calls for more specific community antibiograms to enable a precise approach to antibiotic prescribing and stewardship. Full article
(This article belongs to the Special Issue Antimicrobial Resistance in Enterobacteriaceae and Enterococci)
Show Figures

Figure 1

Figure 1
<p>Map of Washington State divided into PHEPR and colored by adjusted prevalence odds ratio in relation to the reference region (Central) for the five antibiotics.</p>
Full article ">
Back to TopTop